Michael Fuchs
Overview
Explore the profile of Michael Fuchs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
332
Citations
6843
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kumar S, Mohanty A, Mantry P, Schwartz R, Haff M, Therapondos G, et al.
BMC Prim Care
. 2024 Jul;
25(1):265.
PMID: 39033284
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly referred to as nonalcoholic fatty liver disease, impacts 30% of the global population. This educational pilot focused on the role primary care...
12.
Younossi Z, Alqahtani S, Funuyet-Salas J, Romero-Gomez M, Yilmaz Y, Keklikkiran C, et al.
JHEP Rep
. 2024 Jul;
6(7):101066.
PMID: 39022387
Background & Aims: Patients with nonalcoholic fatty liver disease (NAFLD)/metabolic dysfunction-associated steatotic liver disease (MASLD) face a multifaceted disease burden which includes impaired health-related quality of life (HRQL) and potential...
13.
Gessner S, Fuchs M, Pieper L, Tretbar K
Psychother Psychosom Med Psychol
. 2024 Jul;
74(8):311-322.
PMID: 38996429
Objective: People with hearing handicap have to use a whole range of strategies to cope with everyday challenges - they have to self-manage their hearing impairment. While the support of...
14.
Borchmann P, Ferdinandus J, Schneider G, Moccia A, Greil R, Hertzberg M, et al.
Lancet
. 2024 Jul;
404(10450):341-352.
PMID: 38971175
Background: Intensified systemic chemotherapy has the highest primary cure rate for advanced-stage, classical Hodgkin lymphoma but this comes with a cost of severe and potentially life long, persisting toxicities. With...
15.
Freitag T, Fuchs M, Friedrich D, Bieger R, Reichel H, Oltmanns M
J Clin Med
. 2024 Jun;
13(12).
PMID: 38930145
Shorter hip stems have shown promising mid-term results but lack long-term data. High rates of distal cortical hypertrophy (CH) have been described, suggesting a more diaphyseal load transmission. This study...
16.
Meuret S, Lemke S, Hentschel B, Fuchs M
Laryngorhinootologie
. 2024 Jun;
103(12):855-863.
PMID: 38843817
Objective: Teachers are subject to exceptionally high vocal stress throughout their lives and have an increased prevalence of voice disorders. The aim of this study was to evaluate the long-term...
17.
Chang Y, Fuchs M
Bull Math Biol
. 2024 May;
86(7):76.
PMID: 38762579
We give exact and asymptotic counting results for the number of galled networks and reticulation-visible networks with few reticulation vertices. Our results are obtained with the component graph method, which...
18.
Steinert L, Fuchs M, Sigmund A, Didona D, Hudemann C, Mobs C, et al.
J Invest Dermatol
. 2024 Apr;
144(12):2682-2694.e10.
PMID: 38677661
During differentiation, keratinocytes acquire a strong, hyper-adhesive state, where desmosomal cadherins interact calcium ion independently. Previous data indicate that hyper-adhesion protects keratinocytes from pemphigus vulgaris autoantibody-induced loss of intercellular adhesion,...
19.
Egu D, Schmitt T, Ernst N, Ludwig R, Fuchs M, Hiermaier M, et al.
J Invest Dermatol
. 2024 Apr;
144(11):2440-2452.
PMID: 38642796
Pemphigus is a severe blistering disease caused by autoantibodies primarily against the desmosomal cadherins desmoglein (DSG)1 and DSG3, which impair desmosome integrity. Especially for the acute phase, additional treatment options...
20.
Rosenbrock J, Kaul H, Oertel M, Celik E, Linde P, Fan J, et al.
Int J Radiat Oncol Biol Phys
. 2024 Apr;
120(5):1344-1352.
PMID: 38631539
Purpose: Combined modality treatment with chemotherapy followed by consolidation radiation therapy (RT) provides excellent outcomes for patients with early-stage Hodgkin lymphoma. The international standard of care for consolidation RT, involved-site/involved-node...